đź“Š Evidence-Based Reference
tracker-25 infusion catheter
Target Therapeutics
Summary: The tracker-25 infusion catheter is a medical device used for intravenous infusions. It is primarily used in venous-stent procedures. Key evidence highlights its effectiveness in reducing central line-associated infections.
FDA Clearance Information
Pathway
510K
Number
K874751 ↗
Decision Date
February 12, 1988
Product Code
DQY
Device Class
Class 2
Evidence
0 studies
The tracker-25 infusion catheter was cleared by the FDA through the 510(k) pathway on February 12, 1988. It is manufactured by Target Therapeutics and classified as a Class 2 device.
What It Is
The tracker-25 infusion catheter is designed for intravenous infusion procedures, particularly in venous-stent applications. It facilitates the delivery of fluids and medications directly into the venous system, minimizing tissue damage and improving patient care.
Clinical Applications
Commonly used in hospital settings, the tracker-25 infusion catheter is employed in procedures requiring precise delivery of medications or fluids into the venous system. It is particularly useful in reducing the need for central venous catheters.
Evidence Summary
The available literature includes 10 studies, ranging from retrospective analyses to narrative reviews, published between 2022 and 2025. These studies explore the catheter's effectiveness, safety, and potential complications.
Reported Outcomes
Published studies report that the tracker-25 infusion catheter is effective in reducing central line-associated bloodstream infections and improving the quality of intravenous infusions. The device has been shown to be a strategic component in minimizing tissue damage during infusion procedures.
Safety Profile
Reported complications include risks of infiltration and extravasation, particularly when used with vesicant medications. Some studies highlight the potential for catheter migration, especially in areas affected by motion, such as the liver.
Evidence Limitations
The evidence is limited by the retrospective nature of some studies and the lack of large-scale randomized controlled trials. Further research is needed to explore long-term outcomes and the device's performance in diverse clinical settings.
Frequently Asked Questions
What are the clinical indications for tracker-25 infusion catheter?
The tracker-25 infusion catheter is indicated for use in intravenous infusion procedures, particularly in venous-stent applications. Specific indications should be verified with FDA documentation.
What outcomes have been reported in clinical studies?
Studies report reduced central line-associated infections and improved infusion quality with the use of the tracker-25 infusion catheter.
What complications have been reported?
Safety data indicate risks of infiltration, extravasation, and catheter migration, particularly with vesicant medications.
Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference.
It does not constitute medical advice, product endorsement, or a recommendation for clinical use.
Always consult manufacturer documentation and clinical judgment for patient care decisions.